샘플 요청 목록

 카트 문의
시장보고서
상품코드
1655463

세계의 레지오넬라균 검사 시장

Legionella Testing
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 173 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 레지오넬라균 검사 시장은 2030년까지 5억 5,170만 달러에 달할 전망

2024년에 3억 4,300만 달러로 추정되는 세계의 레지오넬라균 검사 시장은 2024-2030년에 CAGR 8.2%로 성장하며, 2030년에는 5억 5,170만 달러에 달할 것으로 예측됩니다. 이 리포트에서 분석한 부문의 하나인 배양법은 CAGR 8.5%를 기록하며, 분석 기간 종료시에는 1억 2,240만 달러에 달할 것으로 예측됩니다. 뇨중항원검사(UAT) 부문의 성장률은 분석 기간 중 CAGR 8.6%로 추정됩니다.

미국 시장은 8,840만 달러로 추정, 중국은 CAGR 12.1%로 성장 예측

미국의 레지오넬라균 검사 시장은 2024년에 8,840만 달러로 추정됩니다. 세계 2위의 경제대국인 중국은 분석 기간인 2024-2030년의 CAGR을 12.1%로 견인하며 2030년까지 1억 3,890만 달러의 시장 규모에 달할 것으로 예측됩니다. 기타 주목해야 할 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 4.3%와 7.3%로 예측됩니다. 유럽에서는 독일이 CAGR 5.1%로 성장할 것으로 예측됩니다.

세계의 레지오넬라균 검사 시장 - 주요 동향과 촉진요인 정리

레지오넬라균 검사가 각 산업 분야에서 중요성이 높아지는 이유는 무엇인가?

레지오넬라균 검사는 공중보건과 물 안전에 대한 전 세계의 인식이 높아짐에 따라 그 중요성이 점점 더 커지고 있습니다. 레지오넬라균은 주로 상수도에 존재하며 심각한 폐렴의 일종인 레지오넬라증을 유발할 수 있습니다. 병원, 호텔, 공공시설과 같은 시설에서 대규모 급수 시스템이 널리 퍼져 있으므로 레지오넬라 균에 대한 정기적인 검사는 감염 발생을 예방하고 거주자의 안전을 보장하는 데 필수적입니다. 정부의 기준과 공중보건 지침에 따라 건강과 안전에 대한 규제에 대한 관심이 높아짐에 따라 특히 물 안전 정책이 엄격한 지역에서는 적극적인 레지오넬라균 검사의 필요성이 더욱 커지고 있습니다.

레지오넬라균 검사 시장의 기술 발전은?

기술의 발전은 레지오넬라균 검사를 보다 빠르고, 정확하고, 다양한 수계에서 쉽게 수행할 수 있도록 변화시켰습니다. 막대한 실험 시간이 필요한 전통적인 배양 방법은 중합효소연쇄반응(PCR) 검사, 신속면역측정법, 효소결합면역흡착법(ELISA)과 같은 첨단 기술로 보완되거나 대체되고 있습니다. 이러한 방법은 높은 민감도와 특이성을 제공하여 레지오넬라균을 신속하게 검출하고 정량화할 수 있습니다. 휴대용 검사 키트와 자동 샘플링 시스템을 통해 현장 검사가 가능해져 현장 검사가 가능해졌습니다. 실시간 모니터링 및 조기 감지 기능을 통해 이러한 혁신은 레지오넬라균 검사의 신뢰성을 높이고 산업계가 보다 엄격한 물 관리 프로토콜을 채택할 수 있게 해줍니다.

어떤 업계에서 레지오넬라균 검사를 채택하고 있는가?

규제 준수와 공중보건에 대한 관심이 높아짐에 따라 의료, 접객업, 물 관리 업계는 레지오넬라균 검사를 선도적으로 도입하고 있습니다. 병원 및 요양시설에서는 약자를 보호하기 위해 레지오넬라 검사를 자주 사용하고, 숙박업계에서는 투숙객의 안전을 보호하기 위해 레지오넬라 검사를 사용하고 있습니다. 또한 산업 시설, 교육 기관 및 지방 자치 단체의 상수도 시스템은 환경 위생 규정을 준수하기 위해 물 안전 계획에 레지오넬라 검사를 통합하고 있습니다. 전 세계에서 지속가능한 물 관리 관행을 장려하는 움직임은 산업계가 종합적인 물 위험 평가의 일환으로 레지오넬라 검사를 도입하도록 더욱 촉구하고 있습니다.

레지오넬라균 검사 시장의 성장은 몇 가지 요인에 의해 발생한다

레지오넬라균 검사 시장의 성장은 건강에 대한 인식 증가, 규제 요건, 검사 방법의 기술 발전 등 여러 가지 요인에 의해 주도되고 있습니다. 선진국과 신흥 국가의 수질 규제 강화로 인해 각 기관들이 레지오넬라 방지 프로그램을 우선순위로 삼고 있습니다. 정기적인 검사가 필요한 의료 시설, 호텔 및 기타 고위험 환경 증가도 주요 촉진요인으로 작용하고 있습니다. 또한 신속 검사 및 현장 진단 툴의 혁신으로 레지오넬라균 검사에 대한 접근성이 확대되어 다양한 부서에서 정기적인 검사를 보다 쉽고 비용 효율적으로 수행할 수 있게 되었습니다. 이러한 요인들이 결합되어 시장은 상승세를 보이고 있습니다.

부문

용도(임상검사법, 환경검사법);&최종 용도(병원, 진단연구소, 진료소, 기타 최종 용도);&검사 유형(배양법, 소변 항원 검사(UAT), 혈청학, 직접 형광 항체 검사(DFA), 핵산 기반 검출법)

조사 대상 기업의 예(주목 41사)

  • Alere, Inc.
  • Aquacert Ltd
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company(BD)
  • BioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • Eiken Chemical Co., Ltd.
  • Hologic, Inc.
  • Idexx Laboratories Inc.
  • Roche Diagnostics
  • Thermo Fischer Scientific, Inc.

목차

제1장 조사 방법

제2장 개요

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장의 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

KSA 25.02.28

Global Legionella Testing Market to Reach US$551.7 Million by 2030

The global market for Legionella Testing estimated at US$343.0 Million in the year 2024, is expected to reach US$551.7 Million by 2030, growing at a CAGR of 8.2% over the analysis period 2024-2030. Culture Methods, one of the segments analyzed in the report, is expected to record a 8.5% CAGR and reach US$122.4 Million by the end of the analysis period. Growth in the Urinary Antigen Test (UAT) segment is estimated at 8.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$88.4 Million While China is Forecast to Grow at 12.1% CAGR

The Legionella Testing market in the U.S. is estimated at US$88.4 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$138.9 Million by the year 2030 trailing a CAGR of 12.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.3% and 7.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.1% CAGR.

Global Legionella Testing Market - Key Trends & Drivers Summarized

Why Is Legionella Testing Gaining Importance Across Industries?

Legionella testing has become increasingly important as global awareness around public health and water safety intensifies. Legionella bacteria, primarily found in water systems, can cause Legionnaires' disease, a potentially severe form of pneumonia. Given the prevalence of large-scale water distribution systems in facilities like hospitals, hotels, and public buildings, regular testing for Legionella is essential to prevent outbreaks and ensure the safety of occupants. This rising focus on health and safety regulations, driven by government standards and public health guidelines, has elevated the need for proactive Legionella testing, particularly in regions with strict water safety policies.

How Is Technology Advancing in the Legionella Testing Market?

Technological advancements have transformed Legionella testing, making it faster, more accurate, and easier to conduct across various water systems. Traditional culture methods, which require extensive lab time, are being supplemented or replaced by advanced techniques like polymerase chain reaction (PCR) testing, rapid immunoassays, and enzyme-linked immunosorbent assay (ELISA) tests. These methods offer high sensitivity and specificity, allowing for faster detection and quantification of Legionella bacteria. Portable testing kits and automated sampling systems are now available, making it feasible to conduct on-site testing. With real-time monitoring and early detection capabilities, these technological innovations have made Legionella testing more reliable, allowing industries to adopt more stringent water management protocols.

Which Industries Are Embracing Legionella Testing?

The healthcare, hospitality, and water management industries are leading adopters of Legionella testing, driven by regulatory compliance and a heightened focus on public health. Hospitals and nursing homes rely on frequent Legionella testing to protect vulnerable populations, while the hospitality sector uses it to safeguard guests. Additionally, industrial facilities, educational institutions, and municipal water systems have integrated Legionella testing into their water safety plans to maintain compliance with environmental health regulations. The global push for sustainable water management practices has further encouraged industries to incorporate Legionella testing as part of comprehensive water risk assessments.

The Growth in the Legionella Testing Market Is Driven by Several Factors

The growth in the Legionella testing market is driven by several factors, including rising health awareness, regulatory requirements, and technological advancements in testing methodologies. Increased regulations around water quality in developed and emerging economies have spurred organizations to prioritize Legionella control programs. The growing number of healthcare facilities, hotels, and other high-risk environments that require regular testing is also a key driver. Additionally, innovations in rapid testing and on-site diagnostic tools have broadened access to Legionella testing, making it easier and more cost-effective for various sectors to implement routine testing. These factors collectively underscore the market's upward trajectory.

SCOPE OF STUDY:

The report analyzes the Legionella Testing market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Application (Clinical Testing Methods, Environmental Testing Methods); End-Use (Hospitals, Diagnostic Laboratories, Clinics, Other End-Uses); Test Type (Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA), Nucleic Acid-based Detection)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 41 Featured) -

  • Alere, Inc.
  • Aquacert Ltd
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company (BD)
  • BioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • Eiken Chemical Co., Ltd.
  • Hologic, Inc.
  • Idexx Laboratories Inc.
  • Roche Diagnostics
  • Thermo Fischer Scientific, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • Legionella Testing - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Awareness of Waterborne Diseases Driving Demand for Testing
    • Increased Demand for Legionella Testing in Healthcare Facilities
    • Growth of the Hospitality Sector Requiring Routine Water Testing
    • Technological Advancements in Rapid Detection Methods
    • Expansion of Building and Facility Maintenance Practices for Water Safety
    • Growing Focus on Routine Testing in Public and Government Buildings
    • Adoption of Automated Testing Solutions for Efficient Water Monitoring
    • Increasing Demand for Point-of-Use Legionella Testing Kits
    • Increased Awareness of Health Risks Associated with Contaminated Water
    • Growth in Industrial Applications Requiring Legionella Control
    • Surge in Smart Water Management Systems for Continuous Monitoring
    • Development of Cost-Effective Testing Solutions for Broad Adoption
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Legionella Testing Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Legionella Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Legionella Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Legionella Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Culture Methods by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Culture Methods by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Culture Methods by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Urinary Antigen Test (UAT) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Urinary Antigen Test (UAT) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Urinary Antigen Test (UAT) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Serology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Serology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Serology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Direct Fluorescence Antibody Test (DFA) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Direct Fluorescence Antibody Test (DFA) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Direct Fluorescence Antibody Test (DFA) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Nucleic Acid-based Detection by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Nucleic Acid-based Detection by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Nucleic Acid-based Detection by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Clinical Testing Methods by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Clinical Testing Methods by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Clinical Testing Methods by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Environmental Testing Methods by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Environmental Testing Methods by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Environmental Testing Methods by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Diagnostic Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Legionella Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 38: USA Recent Past, Current & Future Analysis for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Legionella Testing by Test Type - Percentage Breakdown of Value Sales for Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection for the Years 2015, 2025 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for Legionella Testing by Application - Percentage Breakdown of Value Sales for Clinical Testing Methods and Environmental Testing Methods for the Years 2015, 2025 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: USA 15-Year Perspective for Legionella Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Legionella Testing by Test Type - Percentage Breakdown of Value Sales for Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection for the Years 2015, 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Canada 15-Year Perspective for Legionella Testing by Application - Percentage Breakdown of Value Sales for Clinical Testing Methods and Environmental Testing Methods for the Years 2015, 2025 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Canada 15-Year Perspective for Legionella Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • Legionella Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Japan 15-Year Perspective for Legionella Testing by Test Type - Percentage Breakdown of Value Sales for Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection for the Years 2015, 2025 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Japan 15-Year Perspective for Legionella Testing by Application - Percentage Breakdown of Value Sales for Clinical Testing Methods and Environmental Testing Methods for the Years 2015, 2025 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Japan 15-Year Perspective for Legionella Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • Legionella Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 65: China Recent Past, Current & Future Analysis for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: China 15-Year Perspective for Legionella Testing by Test Type - Percentage Breakdown of Value Sales for Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection for the Years 2015, 2025 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: China 15-Year Perspective for Legionella Testing by Application - Percentage Breakdown of Value Sales for Clinical Testing Methods and Environmental Testing Methods for the Years 2015, 2025 & 2030
    • TABLE 71: China Recent Past, Current & Future Analysis for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: China 15-Year Perspective for Legionella Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • Legionella Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Legionella Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Legionella Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Legionella Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Legionella Testing by Test Type - Percentage Breakdown of Value Sales for Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection for the Years 2015, 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Europe 15-Year Perspective for Legionella Testing by Application - Percentage Breakdown of Value Sales for Clinical Testing Methods and Environmental Testing Methods for the Years 2015, 2025 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Europe 15-Year Perspective for Legionella Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • FRANCE
    • Legionella Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 86: France Recent Past, Current & Future Analysis for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: France 15-Year Perspective for Legionella Testing by Test Type - Percentage Breakdown of Value Sales for Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection for the Years 2015, 2025 & 2030
    • TABLE 89: France Recent Past, Current & Future Analysis for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: France 15-Year Perspective for Legionella Testing by Application - Percentage Breakdown of Value Sales for Clinical Testing Methods and Environmental Testing Methods for the Years 2015, 2025 & 2030
    • TABLE 92: France Recent Past, Current & Future Analysis for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: France Historic Review for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: France 15-Year Perspective for Legionella Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • Legionella Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Germany 15-Year Perspective for Legionella Testing by Test Type - Percentage Breakdown of Value Sales for Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection for the Years 2015, 2025 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Germany 15-Year Perspective for Legionella Testing by Application - Percentage Breakdown of Value Sales for Clinical Testing Methods and Environmental Testing Methods for the Years 2015, 2025 & 2030
    • TABLE 101: Germany Recent Past, Current & Future Analysis for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Germany 15-Year Perspective for Legionella Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Italy 15-Year Perspective for Legionella Testing by Test Type - Percentage Breakdown of Value Sales for Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection for the Years 2015, 2025 & 2030
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Italy 15-Year Perspective for Legionella Testing by Application - Percentage Breakdown of Value Sales for Clinical Testing Methods and Environmental Testing Methods for the Years 2015, 2025 & 2030
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Italy 15-Year Perspective for Legionella Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Legionella Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 113: UK Recent Past, Current & Future Analysis for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: UK 15-Year Perspective for Legionella Testing by Test Type - Percentage Breakdown of Value Sales for Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection for the Years 2015, 2025 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: UK 15-Year Perspective for Legionella Testing by Application - Percentage Breakdown of Value Sales for Clinical Testing Methods and Environmental Testing Methods for the Years 2015, 2025 & 2030
    • TABLE 119: UK Recent Past, Current & Future Analysis for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: UK 15-Year Perspective for Legionella Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 122: Spain Recent Past, Current & Future Analysis for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Spain Historic Review for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: Spain 15-Year Perspective for Legionella Testing by Test Type - Percentage Breakdown of Value Sales for Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection for the Years 2015, 2025 & 2030
    • TABLE 125: Spain Recent Past, Current & Future Analysis for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Spain Historic Review for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Spain 15-Year Perspective for Legionella Testing by Application - Percentage Breakdown of Value Sales for Clinical Testing Methods and Environmental Testing Methods for the Years 2015, 2025 & 2030
    • TABLE 128: Spain Recent Past, Current & Future Analysis for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Spain Historic Review for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Spain 15-Year Perspective for Legionella Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 131: Russia Recent Past, Current & Future Analysis for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Russia Historic Review for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Russia 15-Year Perspective for Legionella Testing by Test Type - Percentage Breakdown of Value Sales for Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection for the Years 2015, 2025 & 2030
    • TABLE 134: Russia Recent Past, Current & Future Analysis for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Russia Historic Review for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Russia 15-Year Perspective for Legionella Testing by Application - Percentage Breakdown of Value Sales for Clinical Testing Methods and Environmental Testing Methods for the Years 2015, 2025 & 2030
    • TABLE 137: Russia Recent Past, Current & Future Analysis for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Russia Historic Review for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Russia 15-Year Perspective for Legionella Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of Europe Historic Review for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of Europe 15-Year Perspective for Legionella Testing by Test Type - Percentage Breakdown of Value Sales for Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection for the Years 2015, 2025 & 2030
    • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of Europe Historic Review for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Rest of Europe 15-Year Perspective for Legionella Testing by Application - Percentage Breakdown of Value Sales for Clinical Testing Methods and Environmental Testing Methods for the Years 2015, 2025 & 2030
    • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Rest of Europe Historic Review for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Rest of Europe 15-Year Perspective for Legionella Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Legionella Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Legionella Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Legionella Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Asia-Pacific 15-Year Perspective for Legionella Testing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Asia-Pacific 15-Year Perspective for Legionella Testing by Test Type - Percentage Breakdown of Value Sales for Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection for the Years 2015, 2025 & 2030
    • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Asia-Pacific Historic Review for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Asia-Pacific 15-Year Perspective for Legionella Testing by Application - Percentage Breakdown of Value Sales for Clinical Testing Methods and Environmental Testing Methods for the Years 2015, 2025 & 2030
    • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Asia-Pacific Historic Review for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Asia-Pacific 15-Year Perspective for Legionella Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Legionella Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 161: Australia Recent Past, Current & Future Analysis for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Australia Historic Review for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Australia 15-Year Perspective for Legionella Testing by Test Type - Percentage Breakdown of Value Sales for Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection for the Years 2015, 2025 & 2030
    • TABLE 164: Australia Recent Past, Current & Future Analysis for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Australia Historic Review for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Australia 15-Year Perspective for Legionella Testing by Application - Percentage Breakdown of Value Sales for Clinical Testing Methods and Environmental Testing Methods for the Years 2015, 2025 & 2030
    • TABLE 167: Australia Recent Past, Current & Future Analysis for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Australia Historic Review for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Australia 15-Year Perspective for Legionella Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • INDIA
    • Legionella Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 170: India Recent Past, Current & Future Analysis for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: India Historic Review for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: India 15-Year Perspective for Legionella Testing by Test Type - Percentage Breakdown of Value Sales for Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection for the Years 2015, 2025 & 2030
    • TABLE 173: India Recent Past, Current & Future Analysis for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: India Historic Review for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: India 15-Year Perspective for Legionella Testing by Application - Percentage Breakdown of Value Sales for Clinical Testing Methods and Environmental Testing Methods for the Years 2015, 2025 & 2030
    • TABLE 176: India Recent Past, Current & Future Analysis for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: India Historic Review for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: India 15-Year Perspective for Legionella Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 179: South Korea Recent Past, Current & Future Analysis for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: South Korea Historic Review for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: South Korea 15-Year Perspective for Legionella Testing by Test Type - Percentage Breakdown of Value Sales for Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection for the Years 2015, 2025 & 2030
    • TABLE 182: South Korea Recent Past, Current & Future Analysis for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: South Korea Historic Review for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: South Korea 15-Year Perspective for Legionella Testing by Application - Percentage Breakdown of Value Sales for Clinical Testing Methods and Environmental Testing Methods for the Years 2015, 2025 & 2030
    • TABLE 185: South Korea Recent Past, Current & Future Analysis for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: South Korea Historic Review for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: South Korea 15-Year Perspective for Legionella Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Rest of Asia-Pacific Historic Review for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Legionella Testing by Test Type - Percentage Breakdown of Value Sales for Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection for the Years 2015, 2025 & 2030
    • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Rest of Asia-Pacific Historic Review for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Rest of Asia-Pacific 15-Year Perspective for Legionella Testing by Application - Percentage Breakdown of Value Sales for Clinical Testing Methods and Environmental Testing Methods for the Years 2015, 2025 & 2030
    • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Asia-Pacific Historic Review for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: Rest of Asia-Pacific 15-Year Perspective for Legionella Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Legionella Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Legionella Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Legionella Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Latin America 15-Year Perspective for Legionella Testing by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Latin America 15-Year Perspective for Legionella Testing by Test Type - Percentage Breakdown of Value Sales for Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection for the Years 2015, 2025 & 2030
    • TABLE 203: Latin America Recent Past, Current & Future Analysis for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Latin America Historic Review for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Latin America 15-Year Perspective for Legionella Testing by Application - Percentage Breakdown of Value Sales for Clinical Testing Methods and Environmental Testing Methods for the Years 2015, 2025 & 2030
    • TABLE 206: Latin America Recent Past, Current & Future Analysis for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Latin America Historic Review for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Latin America 15-Year Perspective for Legionella Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 209: Argentina Recent Past, Current & Future Analysis for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Argentina Historic Review for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: Argentina 15-Year Perspective for Legionella Testing by Test Type - Percentage Breakdown of Value Sales for Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection for the Years 2015, 2025 & 2030
    • TABLE 212: Argentina Recent Past, Current & Future Analysis for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Argentina Historic Review for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 214: Argentina 15-Year Perspective for Legionella Testing by Application - Percentage Breakdown of Value Sales for Clinical Testing Methods and Environmental Testing Methods for the Years 2015, 2025 & 2030
    • TABLE 215: Argentina Recent Past, Current & Future Analysis for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Argentina Historic Review for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 217: Argentina 15-Year Perspective for Legionella Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 218: Brazil Recent Past, Current & Future Analysis for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Brazil Historic Review for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 220: Brazil 15-Year Perspective for Legionella Testing by Test Type - Percentage Breakdown of Value Sales for Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection for the Years 2015, 2025 & 2030
    • TABLE 221: Brazil Recent Past, Current & Future Analysis for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Brazil Historic Review for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 223: Brazil 15-Year Perspective for Legionella Testing by Application - Percentage Breakdown of Value Sales for Clinical Testing Methods and Environmental Testing Methods for the Years 2015, 2025 & 2030
    • TABLE 224: Brazil Recent Past, Current & Future Analysis for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Brazil Historic Review for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 226: Brazil 15-Year Perspective for Legionella Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 227: Mexico Recent Past, Current & Future Analysis for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Mexico Historic Review for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 229: Mexico 15-Year Perspective for Legionella Testing by Test Type - Percentage Breakdown of Value Sales for Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection for the Years 2015, 2025 & 2030
    • TABLE 230: Mexico Recent Past, Current & Future Analysis for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Mexico Historic Review for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 232: Mexico 15-Year Perspective for Legionella Testing by Application - Percentage Breakdown of Value Sales for Clinical Testing Methods and Environmental Testing Methods for the Years 2015, 2025 & 2030
    • TABLE 233: Mexico Recent Past, Current & Future Analysis for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Mexico Historic Review for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 235: Mexico 15-Year Perspective for Legionella Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Rest of Latin America Historic Review for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 238: Rest of Latin America 15-Year Perspective for Legionella Testing by Test Type - Percentage Breakdown of Value Sales for Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection for the Years 2015, 2025 & 2030
    • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Rest of Latin America Historic Review for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 241: Rest of Latin America 15-Year Perspective for Legionella Testing by Application - Percentage Breakdown of Value Sales for Clinical Testing Methods and Environmental Testing Methods for the Years 2015, 2025 & 2030
    • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Rest of Latin America Historic Review for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 244: Rest of Latin America 15-Year Perspective for Legionella Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Legionella Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Legionella Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Legionella Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 247: Middle East 15-Year Perspective for Legionella Testing by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 250: Middle East 15-Year Perspective for Legionella Testing by Test Type - Percentage Breakdown of Value Sales for Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection for the Years 2015, 2025 & 2030
    • TABLE 251: Middle East Recent Past, Current & Future Analysis for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Middle East Historic Review for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 253: Middle East 15-Year Perspective for Legionella Testing by Application - Percentage Breakdown of Value Sales for Clinical Testing Methods and Environmental Testing Methods for the Years 2015, 2025 & 2030
    • TABLE 254: Middle East Recent Past, Current & Future Analysis for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Middle East Historic Review for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 256: Middle East 15-Year Perspective for Legionella Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 257: Iran Recent Past, Current & Future Analysis for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Iran Historic Review for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 259: Iran 15-Year Perspective for Legionella Testing by Test Type - Percentage Breakdown of Value Sales for Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection for the Years 2015, 2025 & 2030
    • TABLE 260: Iran Recent Past, Current & Future Analysis for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Iran Historic Review for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 262: Iran 15-Year Perspective for Legionella Testing by Application - Percentage Breakdown of Value Sales for Clinical Testing Methods and Environmental Testing Methods for the Years 2015, 2025 & 2030
    • TABLE 263: Iran Recent Past, Current & Future Analysis for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Iran Historic Review for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 265: Iran 15-Year Perspective for Legionella Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 266: Israel Recent Past, Current & Future Analysis for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Israel Historic Review for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 268: Israel 15-Year Perspective for Legionella Testing by Test Type - Percentage Breakdown of Value Sales for Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection for the Years 2015, 2025 & 2030
    • TABLE 269: Israel Recent Past, Current & Future Analysis for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Israel Historic Review for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 271: Israel 15-Year Perspective for Legionella Testing by Application - Percentage Breakdown of Value Sales for Clinical Testing Methods and Environmental Testing Methods for the Years 2015, 2025 & 2030
    • TABLE 272: Israel Recent Past, Current & Future Analysis for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Israel Historic Review for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 274: Israel 15-Year Perspective for Legionella Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Saudi Arabia Historic Review for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 277: Saudi Arabia 15-Year Perspective for Legionella Testing by Test Type - Percentage Breakdown of Value Sales for Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection for the Years 2015, 2025 & 2030
    • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Saudi Arabia Historic Review for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 280: Saudi Arabia 15-Year Perspective for Legionella Testing by Application - Percentage Breakdown of Value Sales for Clinical Testing Methods and Environmental Testing Methods for the Years 2015, 2025 & 2030
    • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Saudi Arabia Historic Review for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 283: Saudi Arabia 15-Year Perspective for Legionella Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 284: UAE Recent Past, Current & Future Analysis for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 285: UAE Historic Review for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 286: UAE 15-Year Perspective for Legionella Testing by Test Type - Percentage Breakdown of Value Sales for Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection for the Years 2015, 2025 & 2030
    • TABLE 287: UAE Recent Past, Current & Future Analysis for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 288: UAE Historic Review for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 289: UAE 15-Year Perspective for Legionella Testing by Application - Percentage Breakdown of Value Sales for Clinical Testing Methods and Environmental Testing Methods for the Years 2015, 2025 & 2030
    • TABLE 290: UAE Recent Past, Current & Future Analysis for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 291: UAE Historic Review for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 292: UAE 15-Year Perspective for Legionella Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Rest of Middle East Historic Review for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 295: Rest of Middle East 15-Year Perspective for Legionella Testing by Test Type - Percentage Breakdown of Value Sales for Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection for the Years 2015, 2025 & 2030
    • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Rest of Middle East Historic Review for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 298: Rest of Middle East 15-Year Perspective for Legionella Testing by Application - Percentage Breakdown of Value Sales for Clinical Testing Methods and Environmental Testing Methods for the Years 2015, 2025 & 2030
    • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Rest of Middle East Historic Review for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 301: Rest of Middle East 15-Year Perspective for Legionella Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • AFRICA
    • Legionella Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 302: Africa Recent Past, Current & Future Analysis for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Africa Historic Review for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 304: Africa 15-Year Perspective for Legionella Testing by Test Type - Percentage Breakdown of Value Sales for Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection for the Years 2015, 2025 & 2030
    • TABLE 305: Africa Recent Past, Current & Future Analysis for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Africa Historic Review for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 307: Africa 15-Year Perspective for Legionella Testing by Application - Percentage Breakdown of Value Sales for Clinical Testing Methods and Environmental Testing Methods for the Years 2015, 2025 & 2030
    • TABLE 308: Africa Recent Past, Current & Future Analysis for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 309: Africa Historic Review for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 310: Africa 15-Year Perspective for Legionella Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제